Despite the increased risk of developing tuberculosis in rheumatoid arthritis patients compared to the general population, when comparing the risk of tuberculosis with the use of TNF inhibitors among inflammatory arthropathies, our study and previous studies found no significant difference. This evidence concerns the gene TNF and tuberculosis.